Memantine effects on behaviour in moderately severe to severe Alzheimer’s disease: a post-marketing surveillance study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Memantine effects on behaviour in moderately severe to severe Alzheimer’s disease: a post-marketing surveillance study

Published:2011-05-17 Issue:1 Volume:33 Page:23-31
ISSN:1590-1874
Container-title:Neurological Sciences
language:en
Short-container-title:Neurol Sci

Author:

Clerici Francesca, ,Vanacore Nicola,Elia Antonietta,Spila-Alegiani Stefania,Pomati Simone,Da Cas Roberto,Raschetti Roberto,Mariani Claudio

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Neurology,Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10072-011-0618-0.pdf

Reference36 articles.

1. Mega MS, Cummings JL, Fiorello T, Gornbein J (1996) The spectrum of behavioral changes in Alzheimer’s disease. Neurology 46:130–135

2. Lyketsos CG, Steinberg M, Tschanz JT, Norton MC, Steffens DC, Breitner JC (2000) Mental and behavioral disturbances in dementia: findings from the Cache County Study on memory in aging. Am J Psychiatry 157:708–714

3. Stern Y, Mayeux R, Sano M, Hauser WA, Bush T (1987) Predictors of disease course in patients with probable Alzheimer’s disease. Neurology 37:1649–1653

4. Yaffe K, Fox P, Newcomer R, Sands L, Lindquist K, Dane K, Covinsky KE (2002) Patient and caregiver characteristics and nursing home placement in patients with dementia. Jama 287:2090–2097

5. Wynn ZJ, Cummings JL (2004) Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer’s disease. Dement Geriatr Cogn Disord 17:100–108

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medikamentöse Therapie von BPSD;Verhaltensstörungen bei Demenzerkrankungen;2024

2. A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD);Neurology and Therapy;2023-05-28

3. Cholinergic Antagonists and Behavioral Disturbances in Neurodegenerative Diseases;International Journal of Molecular Sciences;2023-04-07

4. WITHDRAWN: NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer Disease;Combinatorial Chemistry & High Throughput Screening;2022-12-07

5. Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials;Journal of Psychiatric Research;2022-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3